help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-1051
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
145/4/1617    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalma, Y.
Right arrow Articles by Dekel, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalma, Y.
Right arrow Articles by Dekel, N.
Endocrinology Vol. 145, No. 4 1617-1624
Copyright © 2004 by The Endocrine Society

Luteinizing Hormone-Induced Connexin 43 Down-Regulation: Inhibition of Translation

Yael Kalma, Irit Granot, Dalia Galiani, Amihai Barash and Nava Dekel

Department of Biological Regulation (Y.K., D.G., N.D.), The Weizmann Institute of Science, and In Vitro Fertilization Unit (I.G., A.B.), Department of Obstetric and Gynecology, Kaplan Medical Center, Rehovot 76100, Israel

Address all correspondence and requests for reprints to: Nava Dekel, Ph.D., Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel. E-mail: nava.dekel{at}weizmann.ac.il.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The coordinated function of the different compartments of the follicle, the oocyte and the somatic cumulus/granulosa cells, is enabled by the presence of a network of cell-to-cell communication generated by gap junctions. Connexin 43 (Cx43) is the most abundant gap junction protein expressed by the ovarian follicle. The expression of Cx43 is subjected to the control of gonadotropins as follows: FSH up-regulates, whereas LH down-regulates its levels. The aim of this study was to explore the mechanism by which LH reduces the levels of Cx43 and to identify the signal transduction pathway involved in this process. The effect of LH was studied in vitro using isolated intact ovarian follicles. The possible mediators of LH-induced Cx43 down-regulation were examined by incubating the follicles with LH in the presence or absence of inhibitors of protein kinase A (PKA) and of MAPK signaling pathways. Our experiments revealed a 3-h half-life of Cx43 in both control and LH-treated follicles, suggesting that LH did not affect the rate of Cx43 degradation. We further demonstrated that the level of Cx43 mRNA was not significantly influenced by this gonadotropin. However, upon LH administration, [35S]methionine incorporation into Cx43 protein was remarkably reduced. The LH-induced arrest of Cx43 synthesis was counteracted by inhibitors of both the PKA and the MAPK cascades. We show herein that LH inhibits Cx43 expression by reducing its rate of translation and that this effect is mediated by both PKA and MAPK.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE OVARIAN FOLLICLE that consists of the oocyte and the somatic cumulus/granulosa cells functions as one physiological unit. The coordinated function of these different compartments is enabled by the presence of a network of cell-to-cell communication generated by gap junctions (1). Gap junctions are specialized regions in closely opposed membranes of neighboring cells that allow the exchange of small molecules (2). The molecules transmitted through gap junctions from the somatic cells to the oocyte are necessary for oocyte growth and development and play a major role in regulating its meiotic status (3, 4, 5). Recent reports demonstrated that the oocyte not only receives signals from the somatic compartment but also transmits molecules necessary for the growth and development of these cells (Refs. 6, 7, 8, 9 and reviewed in Refs. 10 and 11).

Each gap junction channel consists of two symmetrical hemispheres, termed connexons, that are contributed by two neighboring cells. The connexon is composed of a hexagonal arrangement of six protein subunits referred to as connexins (Cxs). Cxs are members of a growing multigene family that are defined by their molecular weight and share high homology. Numerous types of Cxs (such as Cx26, Cx30.3, Cx32, Cx37, Cx40, Cx43, and Cx45) were identified in ovarian tissues of different mammalian species (12). Cx43, the most abundant member of the Cx family expressed by the ovarian follicle, has been observed on the surface of the granulosa/cumulus cells as well as on the oocyte (13, 14).

Pituitary FSH and LH are the major regulators of ovarian function. FSH has been shown as the main promoter of follicular maturation enhancing granulosa cell proliferation. The control of FSH on folliculogenesis is completed by LH, which, in addition, plays a role in the more advanced stages of follicular development, stimulating oocyte maturation, ovulation, and luteinization (reviewed in Ref. 15).

Gonadotropins also control the expression of Cx43. In general, studies on rat and mouse animal models demonstrated that FSH up-regulates, whereas LH down-regulates, the levels of this protein. Gonadotropins regulation of Cx43 was initially suggested by the changes in Cx43 levels throughout the estrous cycle that correlate with the profile of serum concentration of FSH and LH. These studies demonstrated an increase in the amount of Cx43 in the large antral follicles in a stage at which serum concentrations of FSH are relatively elevated (16, 17). On the other hand, the preovulatory surge of serum concentrations of LH is followed by a drop at the level of Cx43 mRNA and a reduction in the amount of its corresponding protein (16, 17, 18, 19). More direct evidence for the regulatory effects of FSH and LH on the abundance of the ovarian gap junction protein was provided by the exogenous administration of these gonadotropins. In this study, the FSH-like hormone, pregnant mare’s serum gonadotropin, up-regulated the expression of the mRNA encoding Cx43 and the synthesis of the Cx43 protein in the ovarian follicles, whereas an additional injection of human chorionic gonadotropin resulted in a reduction in the mRNA encoding Cx43 and the disappearance of the protein (16). Up-regulation of Cx43 mRNA in response to FSH has also been reported in a rat granulosa cell line (20). The direct effect of LH on the expression of Cx43 analyzed in vitro in isolated intact ovarian follicles demonstrated an inhibitory effect on Cx43 expression. The protein in this system was completely abolished; however, the Cx43 mRNA level was decreased but not eliminated (21).

The findings that a certain amount of Cx43 mRNA could still be detected, whereas the protein is totally absent, suggest that, in addition to transcriptional modification, the effect of LH on Cx43 expression may be also elicited at another level of regulation. The aim of the present study was to explore the mechanism by which LH reduces the levels of Cx43 protein and to identify the signal transduction pathway involved in this process. We assumed that LH either affects the rate of Cx43 degradation or its translation. Our experiments revealed that short exposure to LH results in a reduced rate of translation of the Cx43 protein and that this effect is mediated by protein kinase A (PKA) and the ERK1/2 members of the MAPK family.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents and antibodies
Leibovitz’s L-15 tissue culture medium and FBS were purchased from Biological Industries (Kibbutz Beit Haemek, Israel). Antibiotics were purchased from Bio-Lab Ltd. (Jerusalem, Israel); U0126 and U0124 from Calbiochem. N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide hydrochloride (H-89), forskolin, ß-glycerophosphate, phenylmethylsulfonylfluoride (PMSF), leupeptin, aprotinin, and dithiothreitol (DTT) were from Sigma (St. Louis, MO), and okadaic acid from Biomol. Monoclonal anti-Cx43 antibody was purchased from Transduction Laboratories (Lexington, KY). Monoclonal mouse anti-p-MAPK was kindly provided by Prof. Rony Seger, from The Weizmann Institute of Science (Rehovot, Israel). Polyclonal rabbit anti-MAPK was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) (sc-93). Goat antimouse peroxidase-conjugated antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA), and goat antirabbit alkaline phosphatase (AP)-conjugated antibodies from Promega (Madison, WI).

Animals and tissue collection
The effect of LH was studied using the in vitro system model of isolated intact ovarian follicles (21). Specifically, 23- to 25-d-old wistar female rats were injected sc with 10 IU pregnant mare’s serum gonadotropin (Chrono-gest Intervest, Oss, The Netherlands) and killed 48 h later. The ovaries were removed, and the large antral follicles were separated and grown in suspension in L-15 tissue culture medium containing 5% FBS in the presence or absence of LH (National Institutes of Health, NIDDK-oLH-26). The experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council, National Academy of Science, Bethesda, MD).

The possible mediators of LH-induced Cx43 down-regulation were examined by incubating the follicles with LH in the presence or absence of the inhibitors of the PKA and the MAPK signaling pathways, H-89 and U0126, respectively. Unless mentioned otherwise, the inhibitors were added to the medium at 1 h before LH.

Pulse chase experiments
The follicles were washed with methionine-free medium (Biological Industries) and labeled with 100 µCi/ml [35S]methionine (Amersham, Buckinghamshire, UK; 1000 Ci/mmol) for 2 h in 1 ml methionine-free medium containing 5% dialyzed serum (Biological Industries). The radioactive medium was then washed four times with "cold" medium supplemented with 2 mM methionine (Sigma), and the follicles were chased in medium supplemented with 2 mM methionine in the presence or absence of LH.

RT-PCR
RT-PCR was performed on total RNA prepared by the Tri Reagent (Sigma) method. This (7.5 µg) RNA was employed for cDNA synthesis using Moloney murine leukemia virus reverse transcriptase (Promega, 200 U) and oligo deoxythymidine (0.5 µg, Promega). PCR was performed on 1 µl of the 20-µl cDNA sample. Below are indicated, respectively, the number of cycles and the sequences of 5' and 3' primers used for each of the tested genes: for the gene encoding Cx43, 26 cycles, using 5'CAGATCAGGTGGACTGTTTCCTC3' and 5'GGAGACATAGGCGC-GAGGGGAGCGG3'; for the gene encoding S-16, 19 cycles using 5'CGTTCACCTTGATGAGCCCAT3' and 5'TCCAAGGGTCCGCTGCAGTC3'. The annealing temperature for both genes was 60 C.

Analysis of Cx43 translation
Protein synthesis was analyzed in follicles incubated in 1 ml medium in the presence or absence of LH. After 4 h of incubation, 500 µCi of [35S]methionine was added to the medium for an additional 3 h. The rate of Cx43 protein synthesis was determined in follicles exposed for 1 h to 400 µCi of [35S]methionine that was added to the medium at the indicated time points of their incubation. The follicles were then washed on ice four times with PBS and subjected to immunoprecipitation with anti-Cx43 antibodies.

Immunoprecipitation
Twenty-five follicles were homogenized for 30 sec in 0.2 ml radioimmunoprecipitation (RIPA) buffer containing 137 mM NaCl, 20 mM Tris (pH 7.4), 10% glycerol, 0.1% sodium dodecyl sulfate. 0.5% deoxycholate, 1% Triton X-100, 2 mM EDTA, okadaic acid (0.1 µM), pepstatin (1 µg/ml), leupeptin (1 µg/ml), and 1 mM PMSF. The lysates were then centrifuged at maximum speed for 10 min, followed by supernatants transfer to new tubes and determination of protein concentration (21A ). Equal amounts of proteins (400 µg) were incubated with 1 µg monoclonal anti-Cx43 antibody for 2 h at 4 C followed by the addition of the antimouse IgG agarose beads (A-6531 Sigma) for an additional hour (the beads were washed 4 times with RIPA buffer before usage). The beads were then washed once with RIPA buffer, twice with 0.1 M Tris-HCl (pH8)/0.5 M LiCl buffer, and again with RIPA buffer. The immune proteins were recovered by boiling in sample buffer for 5 min. The beads were centrifuged for 30 sec, and the immune complexes were resolved by SDS-PAGE.

Western blot analysis
Follicles were homogenized for 30 sec in homogenization buffer containing 20 mM Tris (pH 7.5), 250 mM sucrose, supplemented with 10 mM DTT, 2 mM EDTA, 5 mM EGTA, okadaic acid (0.1 µM), pepstatin (1 µg/ml), leupeptin (1 µg/ml), and 1 mM PMSF. Large tissue particles were removed by slow centrifugation for 5 min. The supernatant was recovered, and protein concentration was determined. Twenty micrograms of protein per lane were loaded on 12.5% polyacrylamide gel. After electrophoresis, the proteins were transferred to a nitrocellulose membrane (Hybond-C super, Amersham). After blocking, the membranes were incubated with the relevant antibodies. The following antibodies were used: monoclonal anti-Cx43 antibody (1:250 dilution), rabbit anti-MAPK (1:5,000 dilution), and mouse antiphosphorylated MAPK (p-MAPK, 1:10,000 dilution). Goat antimouse horseradish peroxidase-conjugated and goat antirabbit AP-conjugated second antibodies were used (1:5,000 dilution). The immunoreactive bands were detected using enhanced chemiluminescence reagents (Amersham) and AP reagents (Promega), respectively. Quantitation of the autoradiograms was performed by densitometric analysis using the Pdi 420oe densitometer supported by Quantity One software (Pdi, Huntington Station, NY).

MAPK phosphorylation
The activation state of MAPK (ERK1/2) was determined by Western blot analysis using anti-double phosphorylated MAPK monoclonal antibody that detects the phosphorylated, active MAPK and a rabbit polyclonal serum that detects the total amount of MAPK. At the end of the specified incubation time, the follicles were homogenized in 0.2 ml of homogenization buffer, Buffer H containing 50 mM ß-glycerophosphate, 1.5 mM EGTA, 1 mM EDTA, 1 mM Na-orthovanadate, 1 mM benzamidine, 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 2 µg/ml pepstatin, and 1 mM DTT. The lysates were then centrifuged at maximum speed for 10 min followed by supernatants transfer to new tubes and determination of protein concentration. Equal amounts of proteins were subjected to Western blot analysis. Detection of the immunoreactive band was done as previously described.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
LH does not affect the rate of Cx43 degradation
One mechanism by which LH could possibly down-regulate the levels of Cx43 is by enhancing its degradation. This possibility was examined by pulse chase experiments of intact ovarian follicles incubated with or without LH. These experiments failed to demonstrate any difference in the rate of degradation of Cx43 in follicles exposed to LH (Fig. 1AGo). The half-life of Cx43 in follicles incubated both in the presence and the absence of LH was found to be 3 h (Fig. 1BGo). An alternative mode of LH regulation in this system could be possibly elicited at the level of its mRNA. However, RT-PCR experiments reveal that the steady-state level of the Cx43 mRNA was not significantly influenced after incubation of 8 h with this gonadotropin (Fig. 1CGo). This period of time was sufficient for elimination of most of the protein (Fig. 1DGo).



View larger version (32K):
[in this window]
[in a new window]
 
FIG. 1. The effect of LH on Cx43 degradation and mRNA levels. A, Follicles were labeled for 2 h with [35S]methionine (100 µCi/ml) and chased for 0–19 h in medium with or without LH (1 µg/ml). Follicle protein extracts were immunoprecipitated with anti-Cx43 antibody and then analyzed by SDS-PAGE and autoradiography. B, The autoradiographs were analyzed by densitometry, and the relative amounts of Cx43 found at each time point are depicted graphically. C, Follicles were incubated with or without LH (1 µg/ml) for 8 h. At the end of the incubation, total RNA was extracted and subjected to RT-PCR with specific primers to Cx43 transcript. D, Follicles incubated with or without LH (1 µg/ml) for 8 h were extracted and subjected to SDS-PAGE, followed by Western blot analysis using mouse anti-Cx43 antibodies. A representative result of at least three individual experiments is presented.

 
LH inhibits Cx43 translation
To examine the effect of LH on translatability of Cx43, intact follicles were pulse-labeled with [35S]methionine in the presence or absence of LH. We found that, upon LH administration, [35S]methionine incorporation into Cx43 protein was remarkably reduced (Fig. 2AGo). Analysis of the net incorporation of [35S]methionine into the entire repertoire of cellular proteins in the presence or absence of LH could not detect a difference in total protein synthesis between the two samples (Fig. 2BGo). This last experiment suggests that LH-induced inhibition of translation represents a specific response of Cx43 to this gonadotropin.



View larger version (40K):
[in this window]
[in a new window]
 
FIG. 2. The effect of LH on Cx43 translation. A, Follicles were incubated in the presence or absence of LH (1 µg/ml) for a total time period of 7 h. During the last 3 h of incubation, the follicles were labeled with [35S]methionine (500 µCi/ml). At the end of incubation, the follicles were extracted, Cx43 was immunoprecipitated, and SDS-PAGE and autoradiography analysis was performed. B, Total lysates (25 µg) used for the immunoprecipitation in (A) were subjected to SDS-PAGE, and total protein synthesis was visualized by autoradiography. C, Follicles incubated with LH (1 µg/ml) and labeled at the indicated times with [35S]methionine (400 µCi/ml) were extracted, Cx43 was immunoprecipitated, and analysis by SDS-PAGE and autoradiography was conducted. Graphic representation of the data are also illustrated. D, Follicles incubated with or without LH (1 µg/ml) and labeled at the indicated times with [35S]methionine (400 µCi/ml) were extracted, Cx43 was immunoprecipitated, and analysis by SDS-PAGE and autoradiography was performed. A representative result of at least three individual experiments is presented.

 
We next examined the pattern of net synthesis of Cx43. For this purpose the follicles were labeled with [35S]methionine for a period of 1 h at different intervals after the addition of LH. This experiment revealed that the net synthesis of Cx43, which was not significantly different during the first 3 h of incubation with or without LH, was substantially reduced after 3 h of incubation with this gonadotropin (Fig. 2CGo). To ensure that there is no time-dependent down-regulation of Cx43 synthesis, we compared the pattern of synthesis of Cx34 in follicles incubated with or without LH for 3 h before labeling. As can be seen in Fig. 2DGo, there is no difference in the amount of Cx43 synthesized by follicles immediately after their removal from the ovaries or 3 h later. On the other hand, there was a marked decrease in Cx43 synthesis in follicles that were incubated with LH for this same time period.

PKA is involved in LH-induced inhibition of translation
The classical second messenger for LH action in the ovarian follicle is cAMP, the downstream effector of which is PKA. The possibility that PKA is involved in mediating the LH-induced inhibition of Cx43 translation was addressed using H-89. This isoquinolinesulfonamide was shown to have a potent inhibitory action against PKA, influencing rather weakly the effect of other kinases (22, 23). We found that LH-induced down-regulation of the Cx43 protein was abolished by this inhibitor (Fig. 3AGo), indicating that this effect of LH is indeed mediated by PKA.



View larger version (37K):
[in this window]
[in a new window]
 
FIG. 3. Effect of H-89 on LH and forskolin-induced down-regulation of Cx43 protein. A, Follicles incubated with LH (1 µg/ml) for 12 h in the presence or absence of H-89 (25 µM) were extracted and subjected to SDS-PAGE, followed by Western blot analysis using mouse anti-Cx43 antibodies. B, Follicles incubated with forskolin (25 µM) for 12 h in the presence or absence of H-89 (25 µM) were extracted and subjected to SDS-PAGE, followed by Western blot analysis using mouse anti-Cx43 antibodies. A representative result of at least three individual experiments is presented.

 
It was shown previously that the effect of LH on the level of Cx43 protein could be mimicked by incubating the follicles with forskolin (21), which directly activates the catalytic subunit of the adenylate cyclase, thus elevating cAMP in a receptor-independent manner (24). Along this line, H-89 also prevented the reduction in Cx43 levels promoted by forskolin (Fig. 3BGo).

MAPK is involved in LH-induced inhibition of translation
It has been demonstrated that ERK1/2 are activated by LH in rat granulosa and Leydig cells (25, 26, 27). A more recent study showed that activation of these kinases is essential for gonadotropin-induced oocyte meiotic resumption and cumulus expansion (28). Taken together, these reports suggest that gonadotropin-mediated signaling in the ovary includes members of the MAPK family. To examine the possible involvement of the MAPK cascade in the response to LH in our system, we used U0126, a specific inhibitor of MAPK kinase that is an upstream regulator of ERK1/2. We found that LH-induced down-regulation of Cx43 was abolished by 10 µM of this inhibitor whether it was added before (Fig. 4AGo) or after the administration of LH (Fig. 4BGo). Lower doses of U0126 were less effective (data not shown). Addition of U0124, a nonreactive derivative of U0126, did not affect the response to LH (Fig. 4AGo). Similarly, U0126, but not U0124, prevented the decrease in Cx43 levels promoted by forskolin (Fig. 4CGo).



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 4. The involvement of the MAPK signal transduction in LH and forskolin-induced down-regulation of Cx43 protein. A, Follicles incubated with LH (0.1 µg/ml) in the presence or absence of either U0126 or U0124 (10 µM) for 20 h, were extracted and subjected to SDS-PAGE, followed by Western blot analysis using mouse anti-Cx43 antibodies. B, Follicles were incubated with LH (1 µg/ml) for a total time period of 7 h. In lane 4, which served as a control, U0126 (10 µM) was added 1 h before, whereas in lanes 5 and 6, this inhibitor was added 1.5 and 3 h after, the onset of LH treatment, respectively. At the end of incubation the follicles were extracted and subjected to SDS-PAGE, followed by Western blot analysis using mouse anti-Cx43 antibodies. C, Follicles incubated with forskolin (25 µM) in the presence or absence of either U0126 or U0124 (10 µM) for 12 h, were extracted and subjected to SDS-PAGE, followed by Western blot analysis using mouse anti-Cx43 antibodies. D, Follicles were incubated with LH (1 µg/ml) for 7 h in the presence or absence of U0126 (10 µM) and labeled for the last 3 h of incubation with [35S]methionine (500 µCi/ml). At the end of the labeling period, proteins were extracted and Cx43 was immunoprecipitated and analyzed by SDS-PAGE and autoradiography. E, Total lysates (25 µg) used for the immunoprecipitation in (D) were subjected to SDS-PAGE, and total protein synthesis was visualized by autoradiography. F, Follicles incubated with LH (1 µg/ml) for different time points were extracted and subjected to SDS-PAGE and Western blot analysis using antiphosphorylated and antitotal MAPK antibodies. A representative result of at least three individual experiments is presented.

 
To confirm the involvement of ERK1/2 in the inhibition of Cx43 synthesis, we monitored the translation of the protein in follicles that were incubated with either LH alone, or those incubated with UO126 before the addition of LH. We found that addition of UO126 abolished the ability of LH to down-regulate the levels of Cx43 protein (Fig. 4DGo). The slight reduction in Cx43 observed in follicles incubated with U0126 alone represents apparently the global effect of this agent on cellular protein synthesis (Fig. 4EGo).

Activation of ERK1/2 by LH in the follicles has been demonstrated in our laboratory previously (Sela-Abramovich, S., et al., unpublished data). We further examined herein the pattern of ERK1/2 activation during LH administration. This experiment revealed that activation of ERK1/2 peaks at 30 min after the addition of LH, and that the high level of activity persists for a few hours (Fig. 4FGo). A reduction in ERKs activity is initially seen at 4 h after the administration of LH.

LH-induced activation of MAPK is not mediated by PKA
We further studied the role of cAMP in mediating ERK1/2 activation. In this experiment, the effect of the PKA inhibitor, H-89, on ERK1/2 activation was examined. We found that, at a concentration that completely blocked LH-induced down-regulation of Cx43 protein, H-89 had no effect either on the basal activity of ERK1/2 or on the LH-induced ERK1/2 activation (Fig. 5Go). On the other hand, as expected, the inhibitor of MAPK kinase activity, U0126, did reduce the basal ERK1/2 activity, as well as the LH-induced ERK1/2 activation (Fig. 5Go).



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 5. Effect of PKA inhibitor on LH-induced MAPK activation. Follicles incubated with LH (1 µg/ml) in the presence or absence of either H-89 (25 µM) or U0126 (10 µM) for 0.5 h were extracted and subjected to SDS-PAGE and Western blot analysis using antiphosphorylated and antitotal MAPK antibodies. A representative result of at least three individual experiments is presented.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
It has been shown previously that exposure to LH results in a total elimination of the Cx43 protein at a time point at which changes in the corresponding mRNA could not be demonstrated (21). Our present study provides evidence that the initial effect of LH on Cx43 expression is elicited at the level of translation. The reduction in Cx43 mRNA at 24 h, reported in our previous studies (16, 21), represents a later response to this gonadotropin. To our knowledge, the negative effect of LH on the synthesis of Cx43 in the ovary represents the first example of hormonally induced inhibition of translation of gap junction proteins.

Expression of a protein can be modulated at different levels of regulation among which transcription, mRNA splicing, mRNA stability, translation, and posttranslation events are included. Any combination of these options is also possible. Most of the studies have been focused on transcriptional regulation. However, it is absolutely obvious that posttranscriptional mechanisms play a central role in regulating proteins expression.

Cx43 is an example of a protein whose regulation was demonstrated thus far only at the level of transcription. The idea of translational regulation was previously suggested by Khan-Dawood et al. (29). These investigators showed that the abundant concentration of the ovarian Cx43 in the midluteal phase becomes undetectable in atretic corpora lutea. Their failure to demonstrate variations in Cx43 mRNA throughout the luteal phase suggests that, in this tissue, it is the modulation of translation, rather than transcription, that determines the availability of this protein. Yet, this idea of translational regulation was neither further established nor attributed to the effect of LH on the expression of Cx43.

Translation is a complex process involving the coordinated function of many proteins, the ribosome and tRNAs. Inhibition of translation in most cases results from interaction of proteins with a specific mRNA that subsequently prevents the access of the ribosome to the translation start codon. Such interactions can occur in the 5' or 3' untranslated regions of an mRNA or within the decoded portion of the molecules (reviewed in Ref. 30).

Resolution of the mechanism that mediates the LH-induced inhibition of Cx43 translation must await further studies. However, the fact that inhibition of Cx43 translation cannot be detected before 3–4 h after LH administration may indicate that the signal transduction pathways activated by LH involve processes other than posttranslational modifications. One such possibility is that LH up-regulates the expression of a gene encoding a protein that, in turn, binds Cx43 mRNA, preventing its translation.

The adenylyl cyclase/cAMP/PKA pathway has been widely accepted as the primary signaling cascade through which LH exerts its action. Upon interaction with its corresponding G protein-coupled receptor, LH promotes cAMP elevation that is followed by PKA activation (31). Other pathways in addition to PKA have been implicated more recently in regulating the steroidogenic action of LH (reviewed in Ref. 32). It is presently established that an important element in gonadotropin-mediated signaling in the ovary includes members of the MAPK family such as ERK1/2. The molecular mechanisms by which G protein-coupled receptors regulate ERK1/2 are poorly understood, but several intracellular signaling elements have been shown to modulate ERK1/2 activation in response to G protein-coupled receptors, among which PKA, protein kinase C, and phosphoinositide 3-kinase are included (reviewed in Refs. 33 and 34).

The fact that inhibitors of PKA and MAPK signal transduction pathways interfered with the negative effect of LH on Cx43 translation implies that both these enzymes participate in mediating the action of this gonadotropin in our system. H-89 is considered as a selective and potent inhibitor of PKA (22). However, a more recent study (23) revealed that three (mitogen- and stress-activated kinase 1, ribosomal protein 56 kinase, and Rho kinase II) other protein kinases were inhibited with a potency similar to that of PKA. Nevertheless, because neither of these kinases has been shown to be activated by cAMP, we are quite confident that inhibition of forskolin (as well as LH)-induced Cx43 down-regulation in our study suggests that this response is mediated by PKA. The finding that inhibition of PKA does not block the LH-induced activation of MAPK seems to suggest that activation of this kinase is PKA independent, and that these two enzymes probably act in parallel to transduce the response to LH. Moreover, inhibition of MAPK signaling that does prevent the effect of forskolin in this system further implies that MAPK activation occurs downstream to elevation of cAMP. Yet, the specific hierarchy of their activation and their downstream substrate proteins should be further established.

Both PKA and MAPK signal transduction pathways have been shown to mediate inhibition of translation of other proteins. For example, cAMP-mediated growth inhibition of lymphoid cells in G1 is due to a rapid down-regulation of cyclin D3 at the level of translation (35). This antiproliferative effect of cAMP in lymphocytes has been shown to be mediated through PKA type I. ERK phosphorylation has also been shown to inhibit the translation of different proteins. For example, it was shown that ERK phosphorylation drives cytoplasmic accumulation of hnRNP (heterogeneous nuclear ribonucleoprotein)-K that mediates inhibition of translation of mRNAs that have a cytidine/uridine-rich differentiation-control element (DICE) in their 3' untranslated region (36). The best-characterized protein regulated by these hnRNPs is 15-lipoxygenase (LOX) (37, 38). Cytidine-rich 15-LOX DICE is a multifunctional cis-element found in the 3'-UTR of numerous eukaryotic mRNAs (39). However, this element is absent in the 3'-UTR of Cx43 mRNA and therefore cannot account for ERK-mediated inhibition of translation of this protein.

Our results show that activation of ERK1/2 in the follicle peaks at 30 min after the addition of LH and persists for several hours. We also demonstrate that inhibition of the MAPK signaling pathway that is introduced after the addition of LH still results in abolishment of the response to this gonadotropin. Taken together, these findings indicate that the prolonged activation of MAPK is instrumental for LH-induced inhibition of translation of Cx43.

To summarize, we demonstrate herein, for the first time, that LH inhibits Cx43 translation and that this effect is mediated by PKA and MAPK. LH is one of the major regulators of ovarian development and function. In response to the preovulatory surge of LH, cell-to-cell communication in the follicle is interrupted, the oocyte resumes meiosis, the mature oocyte is released, and the follicle undergoes luteinization (1, 40). To exert these effects, LH up-regulates the expression of a large repertoire of genes that take part in these processes. Among the induced genes, the early growth regulatory factor-1 (41), CAAT enhancer binding protein ß (42), the progesterone receptor (43, 44), and the steroid acute regulatory protein (45, 46) are included. On the other hand, there are examples of genes, such as P450 17{alpha}-hydroxylase and P450 aromatase (47, 48), that are down-regulated after the LH-surge. The reduction in the levels of these last two enzymes can be accounted for by a decrease in their mRNA (49, 50). However, the effect of LH on Cx43 protein down-regulation that is not subsequent to a reduction in the corresponding mRNA is the first example of a LH-induced negative effect on translation. Nevertheless, to ensure the efficiency of the reduction of the gap junction protein, two mechanisms are operated sequentially: the initial suppression of Cx43 translation, demonstrated herein, and the later, previously reported, inhibition of transcription (16, 21). The combined operation of these two mechanisms emphasizes the crucial role of elimination of Cx43 in the ovulatory follicle. We therefore postulate here that this response to LH may also have a role in the control of ovulation. The gap junctions form a network of strong mechanical bonds interconnecting granulosa cells that encapsulate the oocyte, and the loss of these junctions may facilitate the dissociation of the oocyte and its release from the ovarian follicle.


    Footnotes
 
This work was supported by the Dwek Fund for Biomedical Research.

N.D. is the incumbent of the Phillip M. Klutznick Professorial Chair of Developmental Biology.

Abbreviations: AP, Alkaline phosphatase; Cx, connexin; DICE, differentiation-control element; DTT, dithiothreitol; H-89, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide hydrochloride; hnRNP, heterogeneous nuclear ribonucleoprotein; LOX, lipoxygenase; PKA, protein kinase A; PMSF, phenylmethylsulfonylfluoride.

Received August 13, 2003.

Accepted for publication December 4, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Dekel N 1988 Spatial relationship of follicular cells in the control of meiosis. Prog Clin Biol Res 267:87–101[Medline]
  2. Gilula NB, Reeves OR, Steinbach A 1972 Metabolic coupling, ionic coupling and cell contacts. Nature 235:262–265[CrossRef][Medline]
  3. Brower PT, Schultz RM 1982 Intercellular communication between granulosa cells and mouse oocytes: existence and possible nutritional role during oocyte growth. Dev Biol 90:144–153[CrossRef][Medline]
  4. Dekel N, Lawrence TS, Gilula NB, Beers WH 1981 Modulation of cell-to-cell communication in the cumulus-oocyte complex and the regulation of oocyte maturation by LH. Dev Biol 86:356–362[CrossRef][Medline]
  5. Eppig JJ 1979 A comparison between oocyte growth in coculture with granulosa cells and oocytes with granulosa cell-oocyte junctional contact maintained in vitro. J Exp Zool 209:345–353[CrossRef][Medline]
  6. Canipari R, Epifano O, Siracusa G, Salustri A 1995 Mouse oocytes inhibit plasminogen activator production by ovarian cumulus and granulosa cells. Dev Biol 167:371–378[CrossRef][Medline]
  7. Eppig JJ, Chesnel F, Hirao Y, O’Brien MJ, Pendola FL, Watanabe S, Wigglesworth K 1997 Oocyte control of granulosa cell development: how and why. Hum Reprod 12:127–132[Abstract]
  8. Vanderhyden BC, Caron PJ, Buccione R, Eppig JJ 1990 Developmental pattern of the secretion of cumulus expansion-enabling factor by mouse oocytes and the role of oocytes in promoting granulosa cell differentiation. Dev Biol 140:307–317[CrossRef][Medline]
  9. Vanderhyden BC, Telfer EE, Eppig JJ 1992 Mouse oocytes promote proliferation of granulosa cells from preantral and antral follicles in vitro. Biol Reprod 46:1196–1204[Abstract]
  10. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM 1999 Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 13:1035–1048[Abstract/Free Full Text]
  11. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ 2002 Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296:2178–2180[Abstract/Free Full Text]
  12. Grazul-Bilska AT, Reynolds LP, Redmer DA 1997 Gap junctions in the ovaries. Biol Reprod 57:947–957[CrossRef][Medline]
  13. Granot I, Bechor E, Barash A, Dekel N 2002 Connexin43 in rat oocytes: developmental modulation of its phosphorylation. Biol Reprod 66:568–573[Abstract/Free Full Text]
  14. Risek B, Guthrie S, Kumar N, Gilula NB 1990 Modulation of gap junction transcript and protein expression during pregnancy in the rat. J Cell Biol 110:269–282[Abstract/Free Full Text]
  15. Tsafriri A, Dekel N 1994 Molecular biology of the female reproductive system. In: Findley JK, ed. San Diego: Academic Press, Inc.; 207–258
  16. Granot I, Dekel N 1997 Developmental expression and regulation of the gap junction protein and transcript in rat ovaries. Mol Reprod Dev 47:231–239[CrossRef][Medline]
  17. Wiesen JF, Midgley Jr AR 1993 Changes in expression of connexin 43 gap junction messenger ribonucleic acid and protein during ovarian follicular growth. Endocrinology 133:741–746[Abstract]
  18. Larsen WJ, Tung HN, Polking C 1981 Response of granulosa cell gap junctions to human chorionic gonadotropin (hCG) at ovulation. Biol Reprod 25:1119–1134[Abstract]
  19. Larsen WJ, Wert SE, Brunner GD 1987 Differential modulation of rat follicle cell gap junction populations at ovulation. Dev Biol 122:61–71[CrossRef][Medline]
  20. Sommersberg B, Bulling A, Salzer U, Frohlich U, Garfield RE, Amsterdam A, Mayerhofer A 2000 Gap junction communication and connexin 43 gene expression in a rat granulosa cell line: regulation by follicle-stimulating hormone. Biol Reprod 63:1661–1668[Abstract/Free Full Text]
  21. Granot I, Dekel N 1994 Phosphorylation and expression of connexin-43 ovarian gap junction protein are regulated by luteinizing hormone. J Biol Chem 269:30502–30509[Abstract/Free Full Text]
  22. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254[CrossRef][Medline]
  23. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H 1990 Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267–5272[Abstract/Free Full Text]
  24. Davies SP, Reddy H, Caivano M, Cohen P 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95–105[CrossRef][Medline]
  25. Seamon KB, Daly JW 1981 Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 7:201–224[Medline]
  26. Hirakawa T, Ascoli M 2003 The lutropin/choriogonadotropin receptor-induced phosphorylation of the extracellular signal-regulated kinases in leydig cells is mediated by a protein kinase A-dependent activation of ras. Mol Endocrinol 17:2189–2200[Abstract/Free Full Text]
  27. Salvador LM, Maizels E, Hales DB, Miyamoto E, Yamamoto H, Hunzicker-Dunn M 2002 Acute signaling by the LH receptor is independent of protein kinase C activation. Endocrinology 143:2986–2994[Abstract/Free Full Text]
  28. Seger R, Hanoch T, Rosenberg R, Dantes A, Merz WE, Strauss 3rd JF, Amsterdam A 2001 The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem 276:13957–13964[Abstract/Free Full Text]
  29. Su YQ, Wigglesworth K, Pendola FL, O’Brien MJ, Eppig JJ 2002 Mitogen-activated protein kinase activity in cumulus cells is essential for gonadotropin-induced oocyte meiotic resumption and cumulus expansion in the mouse. Endocrinology 143:2221–2232[Abstract/Free Full Text]
  30. Khan-Dawood FS, Yang J, Dawood MY 1996 Expression of gap junction protein connexin-43 in the human and baboon (Papio anubis) corpus luteum. J Clin Endocrinol Metab 81:835–842[Abstract]
  31. Day DA, Tuite MF 1998 Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol 157:361–371[Abstract]
  32. Cooke BA 1999 Signal transduction involving cyclic AMP-dependent and cyclic AMP-independent mechanisms in the control of steroidogenesis. Mol Cell Endocrinol 151:25–35[CrossRef][Medline]
  33. Conti M 2002 Specificity of the cyclic adenosine 3', 5'-monophosphate signal in granulosa cell function. Biol Reprod 67:1653–1661[Abstract/Free Full Text]
  34. Gutkind JS 1998 The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273:1839–1842[Free Full Text]
  35. Widmann C, Gibson S, Jarpe MB, Johnson GL 1999 Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143–180[Abstract/Free Full Text]
  36. Naderi S, Gutzkow KB, Christoffersen J, Smeland EB, Blomhoff HK 2000 cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation. Eur J Immunol 30:1757–1768[CrossRef][Medline]
  37. Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, Shokat KM, Hentze MW, Ronai Z 2001 ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol 3:325–330[CrossRef][Medline]
  38. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW 1997 mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end. Cell 89:597–606[CrossRef][Medline]
  39. Ostareck-Lederer A, Ostareck DH, Standart N, Thiele BJ 1994 Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3' untranslated region. EMBO J 13:1476–1481[Medline]
  40. Reimann I, Huth A, Thiele H, Thiele BJ 2002 Suppression of 15-lipoxygenase synthesis by hnRNP E1 is dependent on repetitive nature of LOX mRNA 3'-UTR control element DICE. J Mol Biol 315:965–974[CrossRef][Medline]
  41. Schultz RM, Montgomery RR, Belanoff JR 1983 Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis. Dev Biol 97:264–273[CrossRef][Medline]
  42. Espey LL, Ujioka T, Russell DL, Skelsey M, Vladu B, Robker RL, Okamura H, Richards JS 2000 Induction of early growth response protein-1 gene expression in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Endocrinology 141:2385–2391[Abstract/Free Full Text]
  43. Sirois J, Richards JS 1993 Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBP ß promoter element. J Biol Chem 268:21931–21938[Abstract/Free Full Text]
  44. Natraj U, Richards JS 1993 Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology 133:761–769[Abstract]
  45. Park OK, Mayo KE 1991 Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge. Mol Endocrinol 5:967–978[Abstract]
  46. Selvaraj N, Israeli D, Amsterdam A 1996 Partial sequencing of the rat steroidogenic acute regulatory protein message from immortalized granulosa cells: regulation by gonadotropins and isoproterenol. Mol Cell Endocrinol 123:171–177[CrossRef][Medline]
  47. Clark BJ, Stocco DM 1995 Expression of the steroidogenic acute regulatory (StAR) protein: a novel LH-induced mitochondrial protein required for the acute regulation of steroidogenesis in mouse Leydig tumor cells. Endocr Res 21:243–257[Medline]
  48. Hickey GJ, Chen SA, Besman MJ, Shively JE, Hall PF, Gaddy-Kurten D, Richards JS 1988 Hormonal regulation, tissue distribution, and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea: relationship to estradiol biosynthesis. Endocrinology 122:1426–1436[Abstract]
  49. Rodgers RJ, Waterman MR, Simpson ER 1986 Cytochromes P-450scc, P-450(17){alpha}, adrenodoxin, and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase in bovine follicles and corpora lutea. Changes in specific contents during the ovarian cycle. Endocrinology 118:1366–1374[Abstract]
  50. Hedin L, Rodgers RJ, Simpson ER, Richards JS 1987 Changes in content of cytochrome P450(17){alpha}, cytochrome P450scc, and 3-hydroxy-3-methylglutaryl CoA reductase in developing rat ovarian follicles and corpora lutea: correlation with theca cell steroidogenesis. Biol Reprod 37:211–223[Abstract]
  51. Voss AK, Fortune JE 1993 Levels of messenger ribonucleic acid for cytochrome P450 17 {alpha}-hydroxylase and P450 aromatase in preovulatory bovine follicles decrease after the luteinizing hormone surge. Endocrinology 132:2239–2245[Abstract]



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
S. Sela-Abramovich, D. Galiani, N. Nevo, and N. Dekel
Inhibition of Rat Oocyte Maturation and Ovulation by Nitric Oxide: Mechanism of Action
Biol Reprod, June 1, 2008; 78(6): 1111 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Panigone, M. Hsieh, M. Fu, L. Persani, and M. Conti
Luteinizing Hormone Signaling in Preovulatory Follicles Involves Early Activation of the Epidermal Growth Factor Receptor Pathway
Mol. Endocrinol., April 1, 2008; 22(4): 924 - 936.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C.-G. Liang, Y.-Q. Su, H.-Y. Fan, H. Schatten, and Q.-Y. Sun
Mechanisms Regulating Oocyte Meiotic Resumption: Roles of Mitogen-Activated Protein Kinase
Mol. Endocrinol., September 1, 2007; 21(9): 2037 - 2055.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. L. Russell and R. L. Robker
Molecular mechanisms of ovulation: co-ordination through the cumulus complex
Hum. Reprod. Update, May 1, 2007; 13(3): 289 - 312.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y.-Q. Su, M. Nyegaard, M. T. Overgaard, J. Qiao, and L. C. Giudice
Participation of Mitogen-Activated Protein Kinase in Luteinizing Hormone-Induced Differential Regulation of Steroidogenesis and Steroidogenic Gene Expression in Mural and Cumulus Granulosa Cells of Mouse Preovulatory Follicles
Biol Reprod, December 1, 2006; 75(6): 859 - 867.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Tsai-Turton and U. Luderer
Gonadotropin regulation of glutamate cysteine ligase catalytic and modifier subunit expression in rat ovary is subunit and follicle stage specific
Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E391 - E402.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
I. Pfeifer, C. Anderson, R. Werner, and E. Oltra
Redefining the structure of the mouse connexin43 gene: selective promoter usage and alternative splicing mechanisms yield transcripts with different translational efficiencies
Nucleic Acids Res., August 24, 2004; 32(15): 4550 - 4562.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
145/4/1617    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalma, Y.
Right arrow Articles by Dekel, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalma, Y.
Right arrow Articles by Dekel, N.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals